Selvakumar D, et al. – This trial was designed to describe the insulin regimens used at diagnosis by patient age and geographical region as well as to explore differences between and within Australia (AU) and New Zealand (NZ) regarding other aspects of patient management and education. Study authors discovered that practice varies across Australasia by clinician as well as region. They noted that this lack of consensus is probably driven by ongoing debates in the current pediatric diabetes evidence base as well as by differences in clinician and center preference, variations in resources, and interpretations of the influence of various patient factors.

Methods

• They used an online survey of medical professionals caring for children with T1DM in AU and NZ.
• Questions included clinic demographics, insulin regimen/dosing choices, and patient education.

Results

• Of 110 clinicians identified, 100 responded (91%) to the survey.
• The majority of those in AU (69%, P?
• In NZ, for patients?
• Insulin pump therapy was never considered at diagnosis in NZ, but 38% of clinicians in AU considered using pumps at diagnosis in patients <2?years, but rarely in patients aged 2 and over (16%).
• Differences in clinician choices were also seen in relation to starting insulin dose.